| Financial Year |
March 31 2023 |
| Monetary Funds |
350,090,492.40 |
| Held-for-trading Financial Assets |
582,273,038.13 |
| Notes Receivable |
47,742,637.67 |
| Accounts Receivable |
770,240,885.05 |
| Advances to Suppliers |
48,930,915.05 |
| Other Receivables |
12,522,821.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
169,029,816.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,108,146.16 |
| Total Current Assets |
2,153,486,625.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
181,136,763.19 |
| Investment Properties |
-- |
| Fixed Assetes |
367,000,696.88 |
| Under-construction Projects |
452,027,022.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,961,002.75 |
| R&D expenses |
53,457,581.06 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,985,019.83 |
| Deferred Income Tax Assets |
60,089,438.71 |
| Other Non-Current Assets |
1,774,957.20 |
| Sub-Total of Non-Current Assets |
1,529,168,222.69 |
| Total Assets |
3,682,654,848.31 |
| Short-Term Loans |
521,229,096.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,187,670.00 |
| Accounts Payable |
351,957,675.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,743,458.52 |
| Taxes Payable |
2,448,974.48 |
| Interest Payable |
-- |
| Dividend Payable |
600,526.92 |
| Other payables |
107,535,647.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,695,060.27 |
| Other Current Liabilities |
2,439,542.02 |
| Sub-Total of Current Liabilities |
1,074,420,194.20 |
| Long-term Loans |
157,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
22,571,379.12 |
| Deferred Income Tax Liabilities |
8,603,560.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
209,561,249.83 |
| Total Liabilities |
1,283,981,444.03 |
| Paid-In Capital(Or Share Stock) |
207,940,700.00 |
| Capital Surplus |
1,236,566,801.44 |
| Surplus Reserve |
111,038,285.47 |
| LESS:Treasury Stock |
192,676,561.07 |
| Undistributed Profits |
1,036,113,880.27 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,398,673,404.28 |
| Owner's Equity（Stockholder's Equity） |
2,398,673,404.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,682,654,848.31 |
